Trexquant Investment LP trimmed its stake in shares of Cabot Corporation (NYSE:CBT - Free Report) by 25.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,469 shares of the specialty chemicals company's stock after selling 27,954 shares during the period. Trexquant Investment LP owned approximately 0.15% of Cabot worth $6,773,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of CBT. LSV Asset Management lifted its holdings in Cabot by 318.0% in the first quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company's stock valued at $47,476,000 after buying an additional 434,434 shares during the period. American Century Companies Inc. lifted its holdings in Cabot by 13.2% in the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company's stock valued at $124,566,000 after buying an additional 174,921 shares during the period. Nuveen LLC acquired a new position in Cabot in the first quarter valued at approximately $12,365,000. Millennium Management LLC lifted its holdings in Cabot by 67.7% in the fourth quarter. Millennium Management LLC now owns 349,369 shares of the specialty chemicals company's stock valued at $31,901,000 after buying an additional 141,050 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in Cabot by 10,385.0% in the first quarter. GAMMA Investing LLC now owns 141,338 shares of the specialty chemicals company's stock valued at $11,751,000 after buying an additional 139,990 shares during the period. 93.18% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, CEO Sean D. Keohane sold 114,436 shares of the firm's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the completion of the sale, the chief executive officer owned 361,518 shares in the company, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 3.03% of the company's stock.
Cabot Stock Up 0.8%
Shares of CBT stock traded up $0.64 during trading hours on Thursday, hitting $81.03. 117,643 shares of the company were exchanged, compared to its average volume of 418,484. Cabot Corporation has a 52 week low of $70.40 and a 52 week high of $117.46. The business has a 50 day moving average of $77.88 and a two-hundred day moving average of $78.65. The company has a market capitalization of $4.31 billion, a PE ratio of 10.59 and a beta of 0.90. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66.
Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, beating analysts' consensus estimates of $1.80 by $0.10. The firm had revenue of $923.00 million during the quarter, compared to analysts' expectations of $957.29 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.
Cabot Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 11th. Stockholders of record on Friday, August 29th will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Friday, August 29th. Cabot's dividend payout ratio (DPR) is currently 23.53%.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on CBT shares. Wall Street Zen lowered shares of Cabot from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. UBS Group set a $82.00 target price on shares of Cabot and gave the company a "neutral" rating in a research note on Tuesday, August 5th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $92.33.
View Our Latest Analysis on CBT
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.